281
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib and Tislelizumab with or Without Transhepatic Arterial Embolization for Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombus and High Tumor Burden: A Multicenter Retrospective Study

, , , , , , , , , , , , , & show all
Pages 1209-1222 | Received 04 May 2023, Accepted 10 Jul 2023, Published online: 27 Jul 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.